Our expert team is at the heart of all we do

Our team of pharmaceutical experts has been developing our proprietary iCRT-deter technology for the past 8 years, turning it into a wide-ranging multi-solution platform for the pharmaceutical industry.

In addition to offering abuse deterrence, our technology also offers controlled release, solubility enhancement and formulation stabilization.

Our expertise allows us to control and modify iCRT-deter, through our understanding of the materials and processes used, to suit the different physicochemical properties of your drugs – making our solution a true platform technology!

Lucideon Healthcare

Lucideon Healthcare provides novel technology, materials and processing solutions and development support to clients around the world.

We specialize in drug delivery solutions, platforms that deliver controlled release of drugs and abuse deterrent features.

Our experts will work with you every step of the way, from concept to commercialization.

We are part of the Lucideon group, a materials development and commercialization organization, that has over 70 years’ experience of providing materials and processing support to industries globally.

With world-wide characterization and testing laboratories, feasibility and pilot plant capabilities, and multi-disciplinary teams of scientists and engineers, we help our clients to develop the next generation of products and processes.

Tony Kinsella, CEO
Tony Kinsella

Chief Executive


+44 (0)1782 764200    

Dr Sean Borkowski, Business Manager
Dr Sean Borkowski

Healthcare Business Manager


+1 919-504-4004    

Aia Malik, Commercial Development Manager
Aia Malik

Commercial Development Manager


+44 (0)1782 764389    

Mary Beth Sprott
Mary Beth Sprott

Internal Sales Consultant


+1 919-504-4900    

Our Experts